entertainment -WSS

entertainment

author：comprehensive 2025-09-29 01:45:30 - browse：6636

Purple AML cells in blood flow — coverage from STAT — Acute myeloid leukemia cells amid blood flow. Adobe

The Food and Drug Administration issued a change to the warning label for Legend Biotech and Janssen’s myeloma CAR-T, Carvykti or cilta-cel, adding that some secondary blood cancers have occurred following treatment for multiple myeloma with the cell therapy.

While the label means that physicians will have to have a conversation about secondary malignancies occurring after Carvykti treatment, oncologists and CAR-T experts said the label update won’t change anything about the use of Carvykti.

“I do not believe this particular change will have any bearing on patient care,” said Saad Usmani, a myeloma physician and cell therapist at Memorial Sloan Kettering who has also studied Carvykti. That’s partly because physicians already discuss the risk of second cancers due to other cancer therapies including radiation, some targeted therapies, and some chemotherapies, which are necessary in the use of CAR-T. “We do have secondary primary malignancy discussions with patients in the context of transplant and will have to do for CAR-T as well,” Usmani said.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： CDC advisory group OKs chikungunya vaccine

focus

hotspot

WSS

Ohio train derailment: Experts on toxic chemical risks

Study fuels hope CAR

Diversify hospital leadership teams to protect BIPOC patient health

CDC advisory group OKs chikungunya vaccine

Study fuels hope CAR

Ohio train derailment: Experts on toxic chemical risks

hotspot

entertainment

hotspot

Guidelines to prevent youth baseball injuries need more muscle

Mifepristone protocols being wielded by pill's opponents in Supreme Court case

Hepatitis C has a cure — but many Americans still lack access to it

More doctors should go into startup world

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Color Health wants to make cancer screenings convenient

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

'Vaccine

Continuity nursing helped my family in our darkest PICU moments

Using force crossed my mind when examining a defiant young patient

focus

Diversify hospital leadership teams to protect BIPOC patient health

Neuroscience renaissance leads to new crop of psychiatric drugs

10 million people disenrolled from Medicaid over past six months

Readout Newsletter: The latest on Amylyx, Moderna, Novavax

NEJM study measures Covid brain fog, impact on IQ

A clever new way to fix Medicaid and graduate medical education

hotspot

focus

hotspot

hotspot